Real-world frequency and outcomes of intraocular inflammation-related adverse events in eyes with neovascular age-related macular degeneration treated with brolucizumab

被引：0
|
作者：
Mccoy, Jasmyne E. [1 ]
Zubricky, Ryan [2 ]
Donkor, Richard [1 ]
Miller, David G. [1 ]
Sonbolian, Nina [3 ]
Heaney, Andrew [3 ]
Bilano, Ver [3 ]
Karcher, Helene [3 ]
Coney, Joseph M. [1 ]
机构：
[1] Retina Associates Cleveland Inc, Beachwood, OH USA
[2] Geisinger Med Ctr, Danville, PA USA
[3] Novartis AG, Basel, Basel Stadt, Switzerland
来源：
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE | 2023年 / 64卷 / 08期
关键词：
D O I：
暂无
中图分类号：
R77 [眼科学];
学科分类号：
100212 ;
摘要：
2216
引用
收藏
页数：3
相关论文
共 50 条
  • [41] Real-world experience of intravitreal faricimab injection in previously treated neovascular age-related macular degeneration eyes: a case series
    Maria A. Bantounou
    Mohammed Elsheikh
    Adelehin Ijasan
    Cynthia Santiago
    BMC Ophthalmology, 25 (1)
  • [42] A case of recalcitrant neovascular wet age-related macular degeneration treated with Intravitreal Brolucizumab
    Panigrahi, Pradeep Kumar
    PHOTODIAGNOSIS AND PHOTODYNAMIC THERAPY, 2021, 35
  • [43] Real-life experiences with Brolucizumab in recalcitrant neovascular age-related macular degeneration
    Book, Marius
    Ziegler, M.
    Rothaus, K.
    Faatz, H.
    Gutfleisch, M.
    Spital, G.
    Lommatzsch, A.
    Pauleikhoff, D.
    OPHTHALMOLOGE, 2022, 119 (03): : 258 - 264
  • [44] Real-life experiences with Brolucizumab in recalcitrant neovascular age-related macular degeneration
    Book, Marius
    Ziegler, M.
    Rothaus, K.
    Faatz, H.
    Gutfleisch, M.
    Spital, G.
    Lommatzsch, A.
    Pauleikhoff, D.
    OPHTHALMOLOGIE, 2022, 119 (03): : 258 - 264
  • [45] Short-Term Treatment Outcomes of Brolucizumab in Patients with Neovascular Age-Related Macular Degeneration: A Multicentre Indian Real-World Evidence Study
    Chakraborty, Debdulal
    Thakkar, Milan
    Venkatesh, Ramesh
    Roy, Sangeeta
    Bhavsar, Maulik
    Karcher, Helene
    CLINICAL OPHTHALMOLOGY, 2023, 17 : 2295 - 2307
  • [46] Clinical Outcomes of Intravitreal Brolucizumab Injection for Refractory Neovascular Age-related Macular Degeneration
    Lee, Jun Young
    Park, No Hae
    Kwon, Han Jo
    Park, Sung Who
    Byon, Ik Soo
    JOURNAL OF THE KOREAN OPHTHALMOLOGICAL SOCIETY, 2024, 65 (09): : 596 - 604
  • [47] Long-term efficacy and safety of brolucizumab in neovascular age-related macular degeneration: A multicentre retrospective real-world study
    Kim, Dong Ju
    Kim, Dong Geun
    Kwak, Hyun Duck
    Jang, Jae Yong
    Ji, Yong-Sok
    Lee, Seung Hyun
    Lee, Eun Kyoung
    Park, Kyu Hyung
    Kim, Jae Hui
    Lee, Jun Sung
    Song, Yumi
    Kim, Seong Taeck
    Shin, Min Ho
    Kim, Min
    Park, Sang Jun
    Joo, Kwangsic
    Sagong, Min
    Lee, Christopher Seungkyu
    Woo, Se Joon
    ACTA OPHTHALMOLOGICA, 2024, 102 (07) : e1018 - e1028
  • [48] Efficacy and safety of brolucizumab in age-related macular degeneration: A systematic review of real-world studies
    Baumal, Caroline R.
    Sorensen, Torben Lykke
    Karcher, Helene
    Freitas, Rita L.
    Becher, Anja
    Balez, Sebastien
    Clemens, Andreas
    Singer, Michael
    Kodjikian, Laurent
    ACTA OPHTHALMOLOGICA, 2023, 101 (02) : 123 - 139
  • [49] RETINAL VASCULITIS OR VASCULAR OCCLUSION AFTER BROLUCIZUMAB FOR NEOVASCULAR AGE-RELATED MACULAR DEGENERATION A Systematic Review of Real-World Evidence
    Wykoff, Charles C.
    Matsumoto, Hidetaka
    Barakat, Mark R.
    Karcher, Helene
    Lozama, Anthony
    Mayhook, Andrew
    Oshagbemi, Olorunfemi A.
    Zorina, Olessia
    Hassan, Tarek S.
    Khanani, Arshad M.
    Heier, Jeffrey S.
    RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, 2023, 43 (07): : 1051 - 1063
  • [50] Intravitreal Brolucizumab for Neovascular Age-Related Macular Degeneration in a Vitrectomized Eye
    Maggio, Emilia
    Alfano, Alessandro
    Mete, Maurizio
    Pertile, Grazia
    CASE REPORTS IN OPHTHALMOLOGY, 2022, 13 (03): : 736 - 743
12345